WELLS FARGO & COMPANY/MN - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$4,418,000
-60.4%
25,558
-73.6%
0.00%
-75.0%
Q4 2014$11,147,000
-87.7%
96,984
-83.3%
0.00%
-89.5%
Q3 2014$90,501,000
-24.2%
579,252
-40.2%
0.04%
-22.4%
Q2 2014$119,434,000
+2.6%
968,162
-13.8%
0.05%0.0%
Q1 2014$116,402,000
+16.9%
1,123,510
+1.5%
0.05%
+14.0%
Q4 2013$99,598,000
+1894.4%
1,107,394
+1383.0%
0.04%
+2050.0%
Q3 2013$4,994,000
+17.8%
74,673
+16.5%
0.00%0.0%
Q2 2013$4,240,00064,1070.00%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders